Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
2010204N 08Rik | |
NM_001081137 |
RIKEN cDNA 2010204N08 gene (2010204N08Rik), mRNA [NM_001081137] |
KLA | .99 |
.98 |
1.00 |
.96 |
.98 |
.98 |
.99 |
| ATP | .96 |
.98 |
1.06 |
1.14 |
.98 |
.97 |
.99 |
| KLA/ATP | .98 |
1.05 |
1.06 |
1.04 |
.99 |
.98 |
1.94 |
|
AK078587
| |
AK078587 |
11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] |
KLA | 1.37 |
1.28 |
1.13 |
1.06 |
1.15 |
1.31 |
1.22 |
| ATP | 1.04 |
1.08 |
1.21 |
1.22 |
1.27 |
1.12 |
1.14 |
| KLA/ATP | 1.48 |
1.66 |
1.97 |
1.26 |
1.17 |
1.03 |
1.28 |
|
Akt1 | |
NM_009652 |
thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] |
KLA | .80 |
.80 |
.75 |
.75 |
.71 |
.70 |
.82 |
| ATP | 1.00 |
1.02 |
.76 |
.85 |
.76 |
.68 |
.84 |
| KLA/ATP | .82 |
.80 |
.64 |
.68 |
.67 |
.61 |
.72 |
|
Akt2 | |
NM_007434 |
thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] |
KLA | 1.45 |
1.49 |
1.81 |
1.61 |
1.83 |
1.17 |
.92 |
| ATP | 1.12 |
1.12 |
1.00 |
1.28 |
1.20 |
.94 |
1.06 |
| KLA/ATP | 1.48 |
1.70 |
1.69 |
1.58 |
1.57 |
1.32 |
1.27 |
|
Akt3 | |
NM_011785 |
thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] |
KLA | 3.42 |
3.45 |
5.31 |
5.16 |
4.65 |
3.80 |
2.12 |
| ATP | 1.12 |
1.22 |
1.10 |
1.37 |
1.02 |
1.11 |
1.56 |
| KLA/ATP | 3.72 |
4.17 |
4.62 |
4.64 |
2.74 |
2.05 |
3.82 |
|
Amy1 | |
NM_007446 |
amylase 1, salivary (Amy1), transcript variant 1, mRNA [NM_007446] |
KLA | 1.03 |
1.01 |
1.14 |
1.07 |
1.06 |
1.13 |
1.16 |
| ATP | .99 |
.98 |
1.08 |
1.06 |
1.09 |
1.18 |
1.11 |
| KLA/ATP | 1.06 |
1.10 |
1.19 |
1.13 |
1.16 |
1.43 |
1.21 |
|
Atp1a1 | |
NM_144900 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] |
KLA | .78 |
.94 |
.68 |
.81 |
.62 |
.55 |
.75 |
| ATP | 1.02 |
1.05 |
.86 |
.85 |
1.77 |
2.54 |
1.11 |
| KLA/ATP | .83 |
.99 |
.80 |
.75 |
.91 |
1.15 |
.68 |
|
Atp1a2 | |
NM_178405 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] |
KLA | 1.03 |
.98 |
1.03 |
1.05 |
1.03 |
.98 |
1.02 |
| ATP | 1.03 |
.98 |
1.06 |
1.05 |
1.05 |
.93 |
1.07 |
| KLA/ATP | 1.04 |
1.05 |
1.02 |
1.02 |
.98 |
.92 |
1.02 |
|
Atp1a3 | |
AK053751 |
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] |
KLA | .88 |
.87 |
.74 |
.80 |
.84 |
.88 |
.93 |
| ATP | .96 |
.83 |
.80 |
.88 |
.94 |
.89 |
1.15 |
| KLA/ATP | .89 |
.86 |
.79 |
.90 |
.93 |
.84 |
.92 |
|
Atp1a3 | |
NM_144921 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] |
KLA | .99 |
.87 |
.96 |
.86 |
.81 |
.61 |
.52 |
| ATP | 1.22 |
1.21 |
1.16 |
1.38 |
1.27 |
.92 |
1.30 |
| KLA/ATP | .96 |
1.10 |
1.17 |
1.42 |
1.11 |
.91 |
.93 |
|
Atp1b1 | |
NM_009721 |
ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] |
KLA | .97 |
1.02 |
1.08 |
.98 |
.95 |
1.01 |
1.09 |
| ATP | 1.07 |
1.05 |
1.09 |
1.09 |
1.02 |
1.17 |
1.11 |
| KLA/ATP | .99 |
.99 |
.93 |
1.02 |
1.00 |
1.07 |
1.04 |
|
Atp1b2 | |
NM_013415 |
ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] |
KLA | 1.18 |
1.09 |
1.11 |
1.12 |
1.16 |
1.12 |
1.15 |
| ATP | .95 |
.98 |
.99 |
1.26 |
1.06 |
1.10 |
1.07 |
| KLA/ATP | 1.15 |
1.16 |
1.09 |
1.19 |
1.27 |
1.13 |
1.02 |
|
Atp1b3 | |
NM_007502 |
ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] |
KLA | 1.86 |
2.10 |
2.25 |
2.21 |
2.68 |
3.26 |
3.45 |
| ATP | 1.08 |
1.09 |
.93 |
1.13 |
1.55 |
2.14 |
2.38 |
| KLA/ATP | 1.95 |
2.10 |
1.84 |
2.34 |
2.20 |
2.96 |
4.69 |
|
Atp1b4 | |
NM_133690 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] |
KLA | .99 |
1.02 |
1.03 |
1.01 |
.95 |
.90 |
1.00 |
| ATP | 1.00 |
1.05 |
1.04 |
.98 |
1.07 |
.98 |
.97 |
| KLA/ATP | 1.00 |
1.05 |
1.03 |
1.04 |
.96 |
.97 |
1.01 |
|
Cacna1d | |
NM_001083616 |
calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] |
KLA | 1.57 |
1.58 |
2.50 |
3.62 |
4.55 |
2.93 |
.99 |
| ATP | 1.12 |
.99 |
.97 |
.94 |
.75 |
1.71 |
1.48 |
| KLA/ATP | 1.47 |
1.51 |
1.82 |
1.56 |
1.67 |
2.93 |
4.60 |
|
Cacna1d | |
NM_028981 |
calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] |
KLA | 1.20 |
1.26 |
1.43 |
1.62 |
2.07 |
1.66 |
1.00 |
| ATP | 1.03 |
1.03 |
.97 |
.97 |
.93 |
1.20 |
1.26 |
| KLA/ATP | 1.16 |
1.12 |
1.10 |
1.14 |
1.08 |
1.44 |
2.56 |
|
Fxyd2 | |
NM_052823 |
FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] |
KLA | 1.07 |
.97 |
1.09 |
.98 |
1.02 |
.96 |
.83 |
| ATP | 1.07 |
1.22 |
1.00 |
1.14 |
1.00 |
1.22 |
4.11 |
| KLA/ATP | 1.06 |
1.11 |
.96 |
1.13 |
.98 |
1.01 |
1.02 |
|
G6pc | |
NM_008061 |
glucose-6-phosphatase, catalytic (G6pc), mRNA [NM_008061] |
KLA | .96 |
.94 |
1.04 |
1.07 |
1.09 |
1.06 |
1.02 |
| ATP | .98 |
1.05 |
1.09 |
1.04 |
1.05 |
1.00 |
1.01 |
| KLA/ATP | 1.03 |
1.05 |
1.06 |
.96 |
1.02 |
1.00 |
.99 |
|
G6pc2 | |
NM_021331 |
glucose-6-phosphatase, catalytic, 2 (G6pc2), mRNA [NM_021331] |
KLA | .99 |
1.03 |
1.00 |
.98 |
.95 |
1.02 |
.98 |
| ATP | .95 |
1.06 |
.97 |
1.08 |
1.16 |
1.26 |
1.04 |
| KLA/ATP | .94 |
.99 |
1.05 |
6.99 |
3.55 |
1.48 |
1.11 |
|
G6pc3 | |
NM_175935 |
glucose 6 phosphatase, catalytic, 3 (G6pc3), mRNA [NM_175935] |
KLA | .88 |
.89 |
.89 |
.80 |
.75 |
.68 |
.88 |
| ATP | .99 |
1.05 |
.95 |
1.14 |
.92 |
.64 |
.81 |
| KLA/ATP | .92 |
.90 |
.79 |
.94 |
.70 |
.62 |
.58 |
|
Hk1 | |
J05277 |
gb|Mouse hexokinase mRNA, complete cds [J05277] |
KLA | 1.49 |
1.45 |
1.66 |
1.78 |
1.51 |
1.29 |
.99 |
| ATP | 1.11 |
1.05 |
1.15 |
1.20 |
2.31 |
2.17 |
1.09 |
| KLA/ATP | 1.63 |
1.51 |
1.70 |
1.47 |
1.94 |
1.92 |
1.40 |
|
Hk1 | |
NM_010438 |
hexokinase 1 (Hk1), nuclear gene encoding mitochondrial protein, mRNA [NM_010438] |
KLA | 1.58 |
1.75 |
2.05 |
1.84 |
1.96 |
1.67 |
1.31 |
| ATP | 1.06 |
1.25 |
1.01 |
1.49 |
2.23 |
1.79 |
1.20 |
| KLA/ATP | 1.87 |
1.96 |
1.51 |
1.93 |
1.71 |
1.94 |
1.72 |
|
Hk2 | |
NM_013820 |
hexokinase 2 (Hk2), mRNA [NM_013820] |
KLA | 4.09 |
4.09 |
3.17 |
2.37 |
1.53 |
1.62 |
2.02 |
| ATP | .98 |
.92 |
1.08 |
2.24 |
3.82 |
3.86 |
.97 |
| KLA/ATP | 4.07 |
3.94 |
4.17 |
3.53 |
5.42 |
4.65 |
1.54 |
|
Hk3 | |
NM_001033245 |
hexokinase 3 (Hk3), nuclear gene encoding mitochondrial protein, mRNA [NM_001033245] |
KLA | 1.52 |
1.68 |
1.94 |
1.85 |
2.21 |
2.89 |
1.98 |
| ATP | 1.01 |
1.07 |
.87 |
.99 |
1.01 |
1.26 |
2.62 |
| KLA/ATP | 1.63 |
1.74 |
1.67 |
1.69 |
1.44 |
2.01 |
3.53 |
|
Hkdc1 | |
NM_145419 |
hexokinase domain containing 1 (Hkdc1), mRNA [NM_145419] |
KLA | 1.10 |
1.08 |
1.12 |
1.12 |
1.02 |
1.07 |
1.04 |
| ATP | .96 |
1.04 |
1.06 |
4.28 |
10.50 |
3.91 |
1.34 |
| KLA/ATP | .98 |
1.04 |
1.14 |
5.33 |
12.44 |
8.68 |
1.77 |
|
Lct | |
NM_001081078 |
lactase (Lct), mRNA [NM_001081078] |
KLA | .93 |
.83 |
.71 |
.83 |
.89 |
.99 |
.84 |
| ATP | 1.03 |
.98 |
.86 |
.92 |
.82 |
.85 |
.85 |
| KLA/ATP | .80 |
.88 |
.75 |
.78 |
.89 |
.87 |
.86 |
|
Mgam | |
AK033548 |
adult male colon cDNA, RIKEN full-length enriched library, clone:9030616M21 product:hypothetical protein, full insert sequence. [AK033548] |
KLA | 1.16 |
1.20 |
1.22 |
1.21 |
1.01 |
1.02 |
1.07 |
| ATP | 1.01 |
1.01 |
1.11 |
2.86 |
5.71 |
5.58 |
1.53 |
| KLA/ATP | 1.24 |
1.24 |
1.29 |
1.64 |
3.84 |
3.69 |
1.98 |
|
Mgam | |
XM_001481277 |
gb|PREDICTED: Mus musculus maltase-glucoamylase (Mgam), mRNA [XM_001481277] |
KLA | 1.03 |
1.04 |
1.03 |
1.04 |
.95 |
.98 |
1.06 |
| ATP | 1.06 |
.94 |
1.05 |
1.42 |
2.38 |
2.12 |
1.16 |
| KLA/ATP | 1.10 |
1.06 |
1.06 |
1.15 |
1.52 |
1.64 |
1.20 |
|
Mm.21312 8 | |
141801344 |
Unknown |
KLA | .96 |
.95 |
.83 |
.77 |
.52 |
.99 |
1.32 |
| ATP | .80 |
.82 |
1.09 |
.80 |
.83 |
1.19 |
1.46 |
| KLA/ATP | .78 |
.92 |
.98 |
.62 |
.71 |
.94 |
1.41 |
|
Mm.25237
| |
141802859 |
Unknown |
KLA | 1.03 |
1.07 |
1.05 |
1.08 |
1.02 |
1.02 |
1.00 |
| ATP | .98 |
1.02 |
.89 |
.99 |
.99 |
1.03 |
1.09 |
| KLA/ATP | .92 |
.94 |
1.11 |
1.03 |
1.02 |
.97 |
1.09 |
|
Mm.25381 9 | |
118130676 |
Unknown |
KLA | 1.81 |
1.88 |
1.96 |
1.62 |
1.89 |
2.44 |
1.56 |
| ATP | .92 |
.91 |
1.24 |
1.01 |
1.16 |
2.06 |
1.95 |
| KLA/ATP | 1.62 |
1.86 |
1.86 |
1.41 |
1.89 |
2.37 |
1.97 |
|
Mm.26105 4 | |
124487274 |
Unknown |
KLA | .95 |
1.04 |
.97 |
.98 |
1.01 |
.94 |
1.10 |
| ATP | 1.00 |
1.06 |
.94 |
1.07 |
1.01 |
1.00 |
.98 |
| KLA/ATP | 1.04 |
.99 |
.93 |
1.01 |
1.11 |
1.07 |
1.04 |
|
Mm.26930
| |
124487296 |
Unknown |
KLA | 1.16 |
1.07 |
1.03 |
1.13 |
1.13 |
1.32 |
1.25 |
| ATP | .99 |
1.00 |
1.05 |
1.24 |
1.38 |
1.37 |
1.06 |
| KLA/ATP | 1.03 |
1.16 |
1.14 |
1.22 |
1.32 |
1.29 |
1.32 |
|
Mm.33401
| |
149255058 |
Unknown |
KLA | 1.03 |
1.07 |
1.00 |
1.03 |
1.01 |
1.03 |
1.06 |
| ATP | 1.12 |
.98 |
1.12 |
1.36 |
2.32 |
2.03 |
1.10 |
| KLA/ATP | 1.03 |
1.00 |
.99 |
1.21 |
1.39 |
1.58 |
1.20 |
|
Pik3ca | |
ENSMUST00000108243 |
ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] |
KLA | 1.07 |
1.01 |
.91 |
.90 |
.98 |
.96 |
.86 |
| ATP | 1.03 |
.87 |
1.12 |
.63 |
1.22 |
1.86 |
.60 |
| KLA/ATP | 1.05 |
.82 |
.91 |
.61 |
1.17 |
1.26 |
.63 |
|
Pik3ca | |
NM_008839 |
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] |
KLA | 1.15 |
1.11 |
1.05 |
.82 |
.99 |
1.03 |
1.27 |
| ATP | .98 |
1.00 |
.79 |
.75 |
.96 |
1.32 |
1.10 |
| KLA/ATP | 1.10 |
.98 |
.64 |
.72 |
.80 |
1.20 |
1.41 |
|
Pik3cb | |
NM_029094 |
phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] |
KLA | 1.06 |
1.06 |
1.03 |
.73 |
.68 |
.98 |
1.69 |
| ATP | 1.04 |
1.21 |
.95 |
1.02 |
.85 |
.93 |
1.73 |
| KLA/ATP | 1.15 |
1.27 |
.73 |
.83 |
.58 |
.81 |
1.81 |
|
Pik3cd | |
NM_008840 |
phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] |
KLA | 2.28 |
2.42 |
3.10 |
4.17 |
3.35 |
2.31 |
1.34 |
| ATP | 1.02 |
.91 |
.99 |
.63 |
.30 |
.67 |
.80 |
| KLA/ATP | 2.14 |
2.23 |
2.70 |
1.51 |
1.17 |
.85 |
.72 |
|
Pik3cd | |
U86587 |
phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] |
KLA | 2.21 |
2.24 |
3.71 |
3.17 |
3.67 |
2.66 |
1.48 |
| ATP | 1.00 |
1.03 |
.93 |
.96 |
.46 |
.75 |
.97 |
| KLA/ATP | 2.27 |
2.32 |
1.97 |
2.02 |
1.01 |
.99 |
.98 |
|
Pik3cg | |
NM_020272 |
phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] |
KLA | .53 |
.53 |
.61 |
.64 |
.97 |
.86 |
.79 |
| ATP | 1.01 |
1.13 |
.88 |
.89 |
.52 |
.53 |
.53 |
| KLA/ATP | .58 |
.53 |
.43 |
.60 |
.40 |
.43 |
.62 |
|
Pik3r1 | |
NM_001077495 |
phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] |
KLA | 1.05 |
1.07 |
1.03 |
1.00 |
1.01 |
1.20 |
.85 |
| ATP | .97 |
1.02 |
1.48 |
1.42 |
1.76 |
1.33 |
1.23 |
| KLA/ATP | 1.11 |
1.12 |
1.06 |
1.17 |
1.24 |
.99 |
1.12 |
|
Pik3r2 | |
NM_008841 |
phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] |
KLA | .50 |
.50 |
.48 |
.43 |
.46 |
.66 |
.75 |
| ATP | .78 |
.68 |
.45 |
.43 |
.28 |
.57 |
1.37 |
| KLA/ATP | .49 |
.38 |
.32 |
.33 |
.38 |
.67 |
1.10 |
|
Pik3r3 | |
NM_181585 |
phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] |
KLA | 1.59 |
1.49 |
1.37 |
1.17 |
1.05 |
1.55 |
1.41 |
| ATP | 1.12 |
1.00 |
1.33 |
1.70 |
2.01 |
2.37 |
2.02 |
| KLA/ATP | 1.63 |
1.54 |
1.58 |
1.70 |
2.43 |
2.68 |
1.92 |
|
Pik3r5 | |
NM_177320 |
phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] |
KLA | 3.57 |
3.58 |
4.16 |
3.54 |
4.11 |
2.59 |
2.39 |
| ATP | 1.08 |
1.08 |
.93 |
1.67 |
3.11 |
1.88 |
1.34 |
| KLA/ATP | 3.91 |
3.70 |
3.30 |
3.80 |
2.70 |
2.04 |
3.00 |
|
Plcb2 | |
NM_177568 |
phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] |
KLA | .70 |
.68 |
.64 |
.67 |
.65 |
.76 |
.88 |
| ATP | .95 |
.94 |
1.04 |
.94 |
.72 |
.57 |
1.19 |
| KLA/ATP | .69 |
.68 |
.72 |
.63 |
.65 |
.55 |
.70 |
|
Prkcb1 | |
NM_008855 |
protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] |
KLA | .92 |
.95 |
.93 |
.78 |
.77 |
1.08 |
1.83 |
| ATP | 1.03 |
1.12 |
1.09 |
1.23 |
.90 |
2.08 |
.96 |
| KLA/ATP | .98 |
.99 |
.82 |
.89 |
.62 |
1.01 |
1.08 |
|
Slc2a2 | |
NM_031197 |
solute carrier family 2 (facilitated glucose transporter), member 2 (Slc2a2), mRNA [NM_031197] |
KLA | 1.01 |
1.03 |
.97 |
1.00 |
1.01 |
1.02 |
1.04 |
| ATP | 1.02 |
.97 |
1.07 |
1.00 |
1.00 |
1.03 |
1.00 |
| KLA/ATP | 1.01 |
1.01 |
.95 |
1.00 |
1.05 |
1.02 |
1.01 |
|
Slc2a5 | |
NM_019741 |
solute carrier family 2 (facilitated glucose transporter), member 5 (Slc2a5), mRNA [NM_019741] |
KLA | .96 |
1.10 |
1.00 |
.95 |
.95 |
1.03 |
.95 |
| ATP | .99 |
1.00 |
.99 |
.99 |
1.28 |
1.15 |
.72 |
| KLA/ATP | .94 |
.94 |
.87 |
.91 |
1.47 |
1.41 |
1.00 |
|
Slc37a4 | |
NM_008063 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 (Slc37a4), mRNA [NM_008063] |
KLA | .61 |
.53 |
.54 |
.63 |
.64 |
.84 |
.82 |
| ATP | .95 |
.70 |
.60 |
.36 |
.29 |
.77 |
.94 |
| KLA/ATP | .53 |
.49 |
.46 |
.32 |
.33 |
.52 |
.72 |
|
Slc5a1 | |
NM_019810 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 (Slc5a1), mRNA [NM_019810] |
KLA | 1.02 |
1.02 |
1.03 |
1.04 |
.99 |
.93 |
1.06 |
| ATP | 1.03 |
1.03 |
1.02 |
1.05 |
1.04 |
.98 |
.97 |
| KLA/ATP | 1.02 |
.94 |
1.02 |
1.03 |
1.03 |
1.04 |
1.02 |
|
Tas1r2 | |
NM_031873 |
taste receptor, type 1, member 2 (Tas1r2), mRNA [NM_031873] |
KLA | .98 |
.97 |
1.09 |
1.07 |
1.04 |
1.07 |
1.11 |
| ATP | .96 |
1.00 |
1.06 |
2.63 |
2.51 |
1.41 |
1.19 |
| KLA/ATP | 1.02 |
1.08 |
1.11 |
2.55 |
2.91 |
1.76 |
1.13 |
|
Tas1r3 | |
NM_031872 |
taste receptor, type 1, member 3 (Tas1r3), mRNA [NM_031872] |
KLA | 1.11 |
1.20 |
1.23 |
1.21 |
1.17 |
1.44 |
1.13 |
| ATP | 1.05 |
1.07 |
1.09 |
1.20 |
1.07 |
1.05 |
1.14 |
| KLA/ATP | 1.18 |
1.18 |
1.03 |
1.19 |
1.18 |
1.10 |
1.25 |
|